UBS Group’s AfterNext HealthTech Acquisition Corp AFTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-291
Closed -$2.97K 10193
2023
Q1
$2.97K Buy
+291
New +$2.95K ﹤0.01% 8409
2022
Q2
Sell
-4,977
Closed -$48K 11336
2022
Q1
$48K Buy
4,977
+3,934
+377% +$38K ﹤0.01% 6548
2021
Q4
$10K Buy
+1,043
New +$10.1K ﹤0.01% 8829

Other funds holding AFTR

UBS Group's AFTR Position: Q2 2023 in Review

UBS Group sold out of AfterNext HealthTech Acquisition Corp (AFTR) in Q2 2023, closing a stake of 291 shares — an estimated $2.97K sold.

UBS Group first reported a position in AFTR in Q4 2021 and held it in 3 quarters. The position peaked at $48K in Q1 2022. 47 funds tracked by Wall St. Rank hold AFTR as of Q2 2023.

  • UBS Group reported no remaining AfterNext HealthTech Acquisition Corp position as of Q2 2023 after selling out during the quarter.
  • UBS Group sold 291 AfterNext HealthTech Acquisition Corp shares in Q2 2023, an estimated $2.97K.
  • UBS Group first reported a position in AfterNext HealthTech Acquisition Corp in Q4 2021 and held it in 3 quarters.
  • UBS Group's AfterNext HealthTech Acquisition Corp position peaked at $48K in Q1 2022.
  • 47 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.